Literature DB >> 23589894

Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.

Can M Sungur1, Yajarayma J Tang-Feldman, Erik Ames, Maite Alvarez, Mingyi Chen, Dan L Longo, Claire Pomeroy, William J Murphy.   

Abstract

Natural killer (NK) cells show differential functionality based on their capability of binding to self-MHC consistent with licensing. Here we show in vivo confirmation of the physiologic effects of licensing with differential effects of NK subsets on anti-murine cytomegalovirus (anti-MCMV) responses after syngeneic hematopoietic stem cell transplantation (HSCT) or regulatory T-cell (Treg) depletion. After HSCT, depletion of licensed NK cells led to far greater viral loads in target organs early after infection compared with nondepleted and unlicensed depleted mice. There was a preferential expansion of licensed, C-type lectin-like activating receptor Ly49H+ NK cells with increased IFNγ production after infection in nondepleted mice post-HSCT and after Treg depletion. Adoptive transfer of licensed NK subsets into immunodeficient hosts provided significantly greater MCMV resistance compared with transfer of total NK populations or unlicensed subsets. In non-HSCT mice, only concurrent depletion of Tregs or TGF-β neutralization resulted in detection of NK licensing effects. This suggests that licensed NK cells are the initial and rapidly responding population of NK cells to MCMV infection, but are highly regulated by Tregs and TGF-β.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589894      PMCID: PMC3645578          DOI: 10.1073/pnas.1218767110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

2.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

3.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

4.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

5.  Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation.

Authors:  Angèle Bénard; Rhodri Ceredig; Antonius G Rolink
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

6.  Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection.

Authors:  Yajarayma J Tang-Feldman; Angela Wojtowicz; G Raymond Lochhead; Merica A Hale; Yueju Li; Claire Pomeroy
Journal:  J Virol Methods       Date:  2005-09-02       Impact factor: 2.014

7.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Authors:  Jeffrey S Miller; Yvette Soignier; Angela Panoskaltsis-Mortari; Sarah A McNearney; Gong H Yun; Susan K Fautsch; David McKenna; Chap Le; Todd E Defor; Linda J Burns; Paul J Orchard; Bruce R Blazar; John E Wagner; Arne Slungaard; Daniel J Weisdorf; Ian J Okazaki; Philip B McGlave
Journal:  Blood       Date:  2005-01-04       Impact factor: 22.113

8.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Authors:  Junli Yu; Glenn Heller; Joseph Chewning; Sungjin Kim; Wayne M Yokoyama; Katharine C Hsu
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.

Authors:  François Ghiringhelli; Cédric Ménard; Magali Terme; Caroline Flament; Julien Taieb; Nathalie Chaput; Pierre E Puig; Sophie Novault; Bernard Escudier; Eric Vivier; Axel Lecesne; Caroline Robert; Jean-Yves Blay; Jacky Bernard; Sophie Caillat-Zucman; Antonio Freitas; Thomas Tursz; Orianne Wagner-Ballon; Claude Capron; William Vainchencker; François Martin; Laurence Zitvogel
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

View more
  24 in total

1.  Licensing delineates helper and effector NK cell subsets during viral infection.

Authors:  Anthony E Zamora; Ethan G Aguilar; Can M Sungur; Lam T Khuat; Cordelia Dunai; G Raymond Lochhead; Juan Du; Claire Pomeroy; Bruce R Blazar; Dan L Longo; Jeffrey M Venstrom; Nicole Baumgarth; William J Murphy
Journal:  JCI Insight       Date:  2017-05-18

2.  CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.

Authors:  Juan Du; Sandra Lopez-Verges; Brandelyn N Pitcher; Jeffrey Johnson; Sin-Ho Jung; Lili Zhou; Katharine Hsu; Myron S Czuczman; Bruce Cheson; Lawrence Kaplan; Lewis L Lanier; Jeffrey M Venstrom
Journal:  Cancer Immunol Res       Date:  2014-06-23       Impact factor: 11.151

3.  Ly49R activation receptor drives self-MHC-educated NK cell immunity against cytomegalovirus infection.

Authors:  Awndre Gamache; John M Cronk; William T Nash; Patryk Puchalski; Alyssa Gillespie; Hairong Wei; Laurie Gray; Marie-Louise Hammarskjold; Wenhao Xu; Michael G Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 4.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

5.  Infiltrating regulatory B cells control neuroinflammation following viral brain infection.

Authors:  Manohar B Mutnal; Shuxian Hu; Scott J Schachtele; James R Lokensgard
Journal:  J Immunol       Date:  2014-11-10       Impact factor: 5.422

Review 6.  Interactions between innate and adaptive lymphocytes.

Authors:  Georg Gasteiger; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2014-08-18       Impact factor: 53.106

7.  Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.

Authors:  Maite Alvarez; Federico Simonetta; Jeanette Baker; Antonio Pierini; Arielle S Wenokur; Alyssa R Morrison; William J Murphy; Robert S Negrin
Journal:  JCI Insight       Date:  2019-06-18

8.  Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment.

Authors:  Maite Alvarez; Kai Sun; William J Murphy
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

9.  Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses.

Authors:  Can M Sungur; Yajarayma J Tang-Feldman; Anthony E Zamora; Maite Alvarez; Claire Pomeroy; William J Murphy
Journal:  Blood       Date:  2013-07-01       Impact factor: 22.113

Review 10.  Positive and negative regulation by NK cells in cancer.

Authors:  Can M Sungur; William J Murphy
Journal:  Crit Rev Oncog       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.